Rare diseases
Investigational molecules
Locations
Back to Hungary346 clinical trials in Pecs, Hungary across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on the Effectiveness and Safety of Efgartigimod PH20 SC for Adults with Systemic Sclerosis
HungaryStudy of trospium chloride and xanomeline tartrate (KarXT) in patients with psychosis associated with Alzheimer's disease
HungaryStudy Comparing Amivantamab and Drug Combination for Patients with Recurrent or Metastatic Colorectal Cancer Without KRAS/NRAS and BRAF Mutations
HungaryStudy of Pozelimab and Cemdisiran for Adults with Geographic Atrophy from Age-Related Macular Degeneration
HungaryStudy on the Safety and Effectiveness of Inclisiran for Children Aged 6 to Under 12 with Familial Hypercholesterolemia
HungaryStudy on the Effectiveness and Safety of Ianalumab for Patients with Diffuse Cutaneous Systemic Sclerosis
HungaryStudy Comparing Amivantamab and Chemotherapy Versus Cetuximab and Chemotherapy for Patients with Advanced Colorectal Cancer
HungaryStudy on Pegaspargase and Rituximab for Treating Children with Acute Lymphoblastic Leukemia
HungaryStudy on Frexalimab, SAR442970, and Rilzabrutinib for Patients Aged 16-75 with Focal Segmental Glomerulosclerosis or Minimal Change Disease
HungaryStudy on the Safety and Effectiveness of HDP-101 for Patients with Relapsed or Refractory Multiple Myeloma
HungaryStudy on the Safety of Encorafenib, Binimetinib, and Ribociclib for Patients with Solid Tumors
HungaryHungaryThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on innovative treatments for chronic rhinosinusitis and asthma, with studies evaluating new therapeutic approaches for both conditions with and without nasal polyps.
Multiple trials investigating novel medications to improve respiratory symptoms and patient quality of life.
Groundbreaking studies in heart failure prevention and cardiomyopathy, exploring new therapeutic options for various cardiovascular conditions.
Advanced research aimed at reducing cardiovascular events and improving patient outcomes.
Innovative research into treatments for systemic sclerosis and Sjögren's syndrome, focusing on novel therapeutic approaches for these challenging conditions.
Studies evaluating new biological treatments to address various autoimmune conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
